YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

An Intervention to Improve Outcomes in Patients With Advanced Cancer

Phase 3

Completed

Conditions: Cancer

Interventions: Behavioral: Symptom Education
Behavioral: Intervention

First Posted Date: 2011-01-07

Last Posted Date: 2016-06-15

Lead Sponsor: Yale University

Target Recruit Count: 146

Registration Number: NCT01272024

Locations: 🇺🇸
Yale New Haven Hospital/Smilow Cancer Hospital, New Haven, Connecticut, United States

Implementation of Practice Standards for ECG Monitoring

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Behavioral: Education

First Posted Date: 2011-01-04

Last Posted Date: 2017-08-31

Lead Sponsor: Yale University

Target Recruit Count: 92057

Registration Number: NCT01269736

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Baystate Medical Center, Springfield, Massachusetts, United States
🇺🇸
Baylor University Medical Center, Dallas, Texas, United States

and more 13 locations

A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope

Terminated

Conditions: Digestive System Diseases

Interventions: Device: Confocal Imaging

First Posted Date: 2010-12-20

Last Posted Date: 2018-02-26

Lead Sponsor: Yale University

Target Recruit Count: 106

Registration Number: NCT01262937

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules

Phase 4

Completed

Conditions: Hepatitis B

Interventions: Biological: Vaccination to prevent hepatitis B virus infection

First Posted Date: 2010-12-14

Last Posted Date: 2010-12-14

Lead Sponsor: Yale University

Target Recruit Count: 595

Registration Number: NCT01259453

Locations: 🇺🇸
Hispanic Health Council, Hartford, Connecticut, United States
🇺🇸
Case Western Reserve Universtiy, Cleveland, Ohio, United States
🇺🇸
DePaul University, Chicago, Illinois, United States

Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers

Not Applicable

Completed

Conditions: Overweight
Obesity
Smoking Cessation

Interventions: Drug: Nicotine patch

First Posted Date: 2010-12-14

Last Posted Date: 2015-09-28

Lead Sponsor: Yale University

Target Recruit Count: 54

Registration Number: NCT01259466

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Progesterone for Postpartum Cocaine Relapse

Not Applicable

Completed

Conditions: Cocaine Abuse
Cocaine Dependence

Interventions: Other: Placebo
Drug: Progesterone

First Posted Date: 2010-11-29

Last Posted Date: 2017-03-28

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01249274

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

Phase 1

Completed

Conditions: Opioid Dependence
Drug Dependence
AIDS
HIV

Interventions: Drug: Extended-Release Naltrexone

First Posted Date: 2010-11-23

Last Posted Date: 2020-03-19

Lead Sponsor: Yale University

Target Recruit Count: 151

Registration Number: NCT01246401

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Baystate Medical Center, Springfield, Massachusetts, United States

Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers

Not Applicable

Completed

Conditions: Parenting Capacities of Substance Abusing Mothers

Interventions: Behavioral: Mothers and Toddlers Program
Behavioral: Parent Education

First Posted Date: 2010-11-15

Last Posted Date: 2020-04-02

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT01240993

Locations: 🇺🇸
The Moms 'n' Kids Program at the APT Foundation, New Haven, Connecticut, United States
🇺🇸
Yale Psychosocial Substance Abuse Research Unit, West Haven, Connecticut, United States

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Phase 4

Completed

Conditions: Pervasive Development Disorders

Interventions: Drug: extended-release guanfacine
Other: placebo

First Posted Date: 2010-11-10

Last Posted Date: 2020-03-31

Lead Sponsor: Yale University

Target Recruit Count: 62

Registration Number: NCT01238575

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Seattle Children's Hospital, Seattle, Washington, United States

and more 2 locations

Tdap Vaccination for Infant Caregivers

Completed

Conditions: Pertussis
Vaccination

Interventions: Other: Survey

First Posted Date: 2010-11-03

Last Posted Date: 2011-07-28

Lead Sponsor: Yale University

Target Recruit Count: 102

Registration Number: NCT01233401

Locations: 🇺🇸
Hospital of St. Raphael, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy